In this Review:
When to add ICS to COPD therapy
Dual bronchodilation: no adverse cardiac impact
E-cigarettes are popular among Irish youth
Endobronchial valve therapy beneficial in homogeneous emphysema
Detecting collateral ventilation by Chartis vs CT scans
Fluticasone furoate/vilanterol in everyday clinical practice
LABA/LAMA vs LABA/ICS in patients with/without prior ICS use
Weight loss improves COPDassociated comorbidities in obese COPD
Consider screening for COPD in diabetes?
Nebulised heparin: a new treatment option for COPD?
Please login below to download this issue (PDF)